[Radiotherapy of lymphogranulomatosis]

The status of radiotherapy of Hodgkin's disease is no longer determined by the staging alone but also by some special risk factors. So a marked improvement of curative radiotherapy becomes possible by close co-operation with chemotherapy, above all in patients with Bulky disease or with constellations having hitherto a considerably deteriorated prognosis in case of exclusive application of radiotherapy. The present study describes the different risk factors and submits the modified therapeutic procedure depending on the different stages.